Merrimack Pharmaceuticals Management
Merrimack Pharmaceuticals employs about 9 people. The company is managed by 9 executives with a total tenure of roughly 26 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Inspection of Merrimack Pharmaceuticals' management performance can provide insight into the company performance.
Merrimack |
Merrimack Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.0107) % which means that it has lost $0.0107 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0112) %, meaning that it created substantial loss on money invested by shareholders. Merrimack Pharmaceuticals' management efficiency ratios could be used to measure how well Merrimack Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Merrimack Pharmaceuticals Workforce Comparison
Merrimack Pharmaceuticals is regarded second in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 1,050. Merrimack Pharmaceuticals maintains roughly 9.0 in number of employees contributing less than 1% to equities under Health Care industry.
Merrimack Pharmaceuticals Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Merrimack Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Merrimack Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Merrimack Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Levy Noah G. over six months ago Acquisition by Levy Noah G. of 1300 shares of Merrimack Pharmaceuticals at 11.2423 subject to Rule 16b-3 | ||
Gary Crocker over six months ago Acquisition by Gary Crocker of 8000 shares of Merrimack Pharmaceuticals subject to Rule 16b-3 | ||
Andersen Eric over six months ago Acquisition by Andersen Eric of 2165 shares of Merrimack Pharmaceuticals at 12.1923 subject to Rule 16b-3 | ||
William Sullivan over a year ago Acquisition by William Sullivan of 60000 shares of Merrimack Pharmaceuticals subject to Rule 16b-3 |
Merrimack Pharmaceuticals Notable Stakeholders
A Merrimack Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Merrimack Pharmaceuticals often face trade-offs trying to please all of them. Merrimack Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Merrimack Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Gary MBA | Treasurer and Presidentident | Profile | |
| Ulrik Nielsen | Chief Scientific Officer and Sr. VP of Research | Profile | |
| Fazal Khan | VP Manufacturing | Profile | |
| Timothy Surgenor | Secretary | Profile | |
| Ellen Forest | Head of Human Resources | Profile | |
| Daryl Drummond | Head of Research | Profile | |
| MBA MBA | Treasurer and President | Profile | |
| ScD Sinskey | CoFounder Advisor | Profile | |
| Geoffrey CFA | Director Communications | Profile |
Merrimack Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Merrimack Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Merrimack Pharmaceuticals within its industry.Merrimack Pharmaceuticals Manpower Efficiency
Return on Merrimack Pharmaceuticals Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 131.2K | |
| Net Loss Per Executive | 131.2K | |
| Working Capital Per Employee | 2.1M | |
| Working Capital Per Executive | 2.1M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Merrimack Stock
If you are still planning to invest in Merrimack Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Merrimack Pharmaceuticals' history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |